Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline resectable and locally advanced pancreatic cancer
Sara Zakem, Adam C. Mueller, Cheryl Meguid, Robert J. Torphy, Douglas E. Holt, Tracey E. Schefter, Wells A. Messersmith, Martin D. McCarter, Marco Del Chiaro, Richard D. Schulick, Karyn A. Goodman
Topics & Concepts
MedicinePerioperativeNeoadjuvant therapyPancreatic cancerChemotherapyRadiation therapySurgeryPancreasCancerRadiologyOncologyInternal medicineBreast cancerPancreatic and Hepatic Oncology ResearchCholangiocarcinoma and Gallbladder Cancer StudiesLung Cancer Diagnosis and Treatment